Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Amrix

Cyclobenzaprine Hydrochloride

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Amrix:

 BioPortfolio Logo
Cephalon Reports Strong Sales and Earnings for the First Quarter 2009 5th May, 2009 Cephalon, Inc.
TREANDA and AMRIX Lead Sales Growth of 19 Percent over First Quarter 2008 Oncology Sales Climb 179 Percent to Reach 15 Percent of Total Sales Success in Business Development and Research &
Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 29th July, 2008 Cephalon, Inc.
FRAZER, Pa., July 29 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today reported second quarter 2008 sales of $485.0 million, compared to sales of $435.2 million for the second quarter

This page has been viewed 20 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Amrix across BioPortfolio, or for Amrix Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.